The AI Accelerator Grant supports international research teams using AI and data-intensive ovarian cancer research to investigate prevention, detection, tumor biology, or treatment resistance and improve survival.
Funder: Ovarian Cancer Research Alliance
Due Dates (Anticipated): June 2027 (LOI) | September 2027 (Full proposal, by invitation)
Funding Amounts: Up to $1 million USD over three years; optional in-kind AWS compute support up to $600,000 USD total
Summary: Supports international teams using AI and data-intensive research to improve ovarian cancer outcomes.
Key Information: Teams need senior lead investigators representing the US, UK, Canada, and Australia.
The Global Ovarian Cancer Research Consortium brings together ovarian cancer research organizations in the United States, United Kingdom, Canada, and Australia. Administered by Ovarian Cancer Research Alliance (OCRA), this grant supports international, data-intensive collaborations that apply artificial intelligence, including machine learning, to ovarian cancer research.
Projects may address prevention, disease initiation and early detection, the tumor ecosystem, treatment resistance, or other scientifically rigorous questions aimed at improving survival. The program encourages innovative approaches, meaningful use of AI, and patient or public partners throughout the research process. OCRA’s Discovery Lab Trusted Research Environment supports computational research, secure data sharing, and collaboration; optional cloud-computing support is available through Amazon Web Services (AWS).